[ Price : $8.95]
Media reports say senior Trump administration officials blocked a promising new psychedelic treatment for severe depression from b...[ Price : $8.95]
President Trump signs a government spending bill that officially reinstates FDAs Rare Pediatric Disease Priority Review Voucher pr...[ Price : $8.95]
Amgen rejects an FDA request asking it to voluntarily withdraw its vasculitis drug Tavneos (avacopan) from the U.S. market due to ...[ Price : $8.95]
FDA grants AstraZeneca and Daiichi Sankyo a priority review for their antibodydrug conjugate Datroway (datopotamab deruxtecan) as ...[ Price : $8.95]
Former CDRH branch chief Morris Waxler, who was involved in the original approval of laser eye surgery (LASIK) and later a promine...[ Price : $8.95]
A new GAO report finds FDAs regulatory responsibilities expanded substantially between fiscal years 2008 and 2024, and now it face...[ Price : $8.95]
FDA sends AstraZeneca a complete response letter rejecting approval of its BLA for a subcutaneous formulation of Saphnelo (anifrol...[ Price : $8.95]
FDA warns Mexicos Unomedical Device about Quality System and Medical Device Reporting violations in its production of insulin infu...